1

OneLife Rolls Out the World’s Most Efficient Air Purifier: OneLife X

OneLife, innovators with a purpose who are committed to saving lives while protecting the planet, today announced the launch of a groundbreaking new product, OneLife X, the world’s most efficient air purifier. With a revolutionary plasma filter (patent pending) built by German scientists, OneLife X silently delivers clinically clean air via a dishwasher-safe filter, making it easy for people […]

Continue Reading
1

Skyharbour’s Partner Company Medaro Mining Completes Airborne Geophysical Survey at Yurchison Uranium Property, Saskatchewan

Skyharbour Resources Ltd.’s (TSX-V: SYH) (OTCQB: SYHBF) (Frankfurt: SC1P) (the “Company”) partner company Medaro Mining (“Medaro”) is pleased to announce that it has completed an airborne geophysical survey at its Yurchison Uranium Property in Athabasca Basin, Northern Saskatchewan.     Location Map of Yurchison Project: https://www.skyharbourltd.com/_resources/maps/Sky_Yurchison_20211209.jpg   Medaro contracted Geodata Solutions GDS Inc. of Laval, Quebec to complete a high-resolution helicopter-borne magnetic […]

Continue Reading
Hexagonal fuel assembly of water-water energetic reactor

Skyharbour’s Partner Company Azincourt Energy Completes Drill Program at the East Preston Uranium Project with Assays Pending

Skyharbour Resources Ltd.’s (TSX-V:SYH) (OTCQB:SYHBF) (Frankfurt:SC1P) (the “Company”) partner company Azincourt Energy (“Azincourt), is pleased to announce that the 2022 exploration program has been completed at the East Preston uranium project, located in the western Athabasca Basin, Saskatchewan, Canada.   Drilling for the 2022 winter season at the East Preston Project commenced in late January and a total of […]

Continue Reading
Assistance and disease alzheimer problems for senior people

ProMIS Neurosciences Presents Preclinical Results of its Experimental Alzheimer’s Vaccine at the 2022 International AD/PDTM Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders

ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of therapeutics targeting misfolded proteins such as toxic oligomers implicated in the development of neurodegenerative diseases, announced today in vivo results of its experimental Alzheimer’s vaccine presented at the AD/PDTM International Conference held in Barcelona Spain, March 15-20, 2022.     […]

Continue Reading
Doctor and Patient in Neuroscience Lab, Doing EEG Scan

ProMIS Neurosciences Announces Fiscal Year 2021 Results

ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF) (“ProMIS” or the “Company”), a biotechnology company focused on the discovery and development of antibody therapeutics targeting misfolded proteins such as toxic oligomers, implicated in the development of neurodegenerative diseases, today announced its operational and financial results for the fiscal year ended December 31, 2021.   “2021 was […]

Continue Reading
1

CANADA CARBON REPORTS ITS PROSPECTING RESULTS ON THE ASBURY PROPERTY

Canada Carbon Inc. (the “Company” or “Canada Carbon” or “CCB”) (TSX-V:CCB), (OTC: BRUZF), (FF:U7N1) is pleased to announce its first assay results from the rock samples taken as part the 2021 geochemical survey on its Asbury Property (the “Property”) (see news release dated July 21st, 2021). Canada Carbon’s objective was to investigate identified conductors located […]

Continue Reading
Storage and utilization of nuclear radioactive waste concept bac

Skyharbour’s Partner Company Azincourt Energy Increases Alteration Zone in Current Drill Program at the East Preston Uranium Project

Skyharbour Resources Ltd.’s (TSX-V:SYH) (OTCQB:SYHBF) (Frankfurt:SC1P) (the “Company”) partner company Azincourt Energy (“Azincourt”), is pleased to provide an update on the current 2022 exploration and drilling program at the East Preston Uranium Project, located in the western Athabasca Basin, Saskatchewan, Canada. Drilling at the East Preston Project commenced on January 24th, and to date 4,301 […]

Continue Reading

ProMIS Neurosciences to Present at the 2022 International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PDTM) and Related Neurological Disorders

ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of therapeutics targeting misfolded proteins such as toxic oligomers implicated in the development of neurodegenerative diseases, announced today that it will be presenting at the upcoming AD/PDTM International Conference, to be held in Barcelona Spain, March 15-20, 2022.      Optimizing vaccine […]

Continue Reading